Hemispherian
Paul Lelieveld’s experience spans more than 25 years in the commercialization of technologies, strategy & business development, M&A, and in selecting, investing and building life science companies; Paul has successfully led investment rounds in several life science companies for investment funds and family offices.
This person is not in the org chart
This person is not in any offices
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.